The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding variation in treatment intensification for de novo metastatic castration-sensitive prostate cancer (mCSPC): A population-based cohort study.
 
Christopher J.D. Wallis
Honoraria - Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Precision Point Specialty; Sesen Bio
Research Funding - Knight Therapeutics
Travel, Accommodations, Expenses - Tolmar
 
Raj Satkunasivam
Consulting or Advisory Role - Intuitive Surgical; Pfizer; Roche
Research Funding - Anchiano (Inst); BMS GmbH & Co. KG (Inst); Colmmune (Inst); Merck (Inst); Pfizer (Inst); Photocure (Inst); QED Therapeutics (Inst); UroGen pharma (Inst)
 
David-Dan Nguyen
No Relationships to Disclose
 
Khatereh J.D. Aminoltejari
No Relationships to Disclose
 
Amanda Elizabeth Hird
No Relationships to Disclose
 
Soumyajit Roy
Employment - Artera (I); Rush University
Research Funding - Swim Across America
 
Scott C. Morgan
Research Funding - Knight Therapeutics (Inst)
 
Shawn Malone
Consulting or Advisory Role - Abbvie; Amgen; Astellas Oncology; AstraZeneca; Bayer; Janssen; Knight Therapeutics
Travel, Accommodations, Expenses - Sanofi; TerSera
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Tersera; Tolmar
 
Rodney H. Breau
Honoraria - Astellas Pharma; Eisai; Knight Therapeutics; Merck; Tersera; Tersera; Tolmar
Research Funding - Tolmar